Monsenso A/S (CPH:MONSO)

Market Cap	44.31M +122.7%
Revenue (ttm)	8.91M -20.2%
Net Income	-7.22M
EPS	-0.11
Shares Out	95.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,237
Open	0.3800
Previous Close	0.3760
Day's Range	0.3800 - 0.4620
52-Week Range	0.0900 - 0.4620
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Monsenso

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psy...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 10
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: MONSO

Financial Performance

In 2025, Monsenso's revenue was 8.91 million, a decrease of -20.22% compared to the previous year's 11.17 million. Losses were -7.22 million, 20.3% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 17, 2026

Data Sources Report a data error